Altapizone

This classification denotes a vasodilating agent with the molecular formula C24H28N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SW3OJS6TOD, chemically known as 4-phenyl-4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-1-piperidinepropionanilide but generally known as altapizone, which bears US NIH Compound Identifier 178135. European Medicines Agency schedules Altapizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05376MIG. The term ALTAPIZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). ALTAPIZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule altapizone under HS 29333999 and SITC 51574. As of Q4 2014, ALTAPIZONE remains the US FDA Preferred Term for this commodity. Altapizone bears US NLM identifiers UMLS ID C2698071 and NCI Concept Code C74423. SMILES: O=C(Nc1ccc(C2=NNC(=O)CC2)cc1)CCN1CCC(CC1)c1ccccc1.